Bayanan Bayani na Kamfanin
Qingdao Jianma Gene Technology Co., Ltd. An kafa a watan Fabrairu 2019, Located in the Industrial Technology Research Institute of Qingdao High-tech Zone, Shandong Province, Shi ne kimiyya da fasaha sha'anin mayar da hankali a kan R & D da kuma samar da na'urorin kiwon lafiya a cikin filin POCT kwayoyin.
Kamfanin yana sanye da wani taron bita na tsarkakewa matakin 100,000 da manyan kayan aikin bincike na kimiyya da na'urorin samar da kayayyaki na kasa da kasa, kuma yana da aikin bincike da ci gaba da samar da aikin murabba'in mita 1,200.
Kamfanin yana da dandamali guda biyu na fasaha na gano nucleic acid (Isothermal nucleic acid detection platform, ASEA nucleic acid fast detection platform) ， Samfuran da aka haɓaka bisa wannan dandamali suna da halaye na sauƙi, saurin gudu, ƙayyadaddun ƙayyadaddun bayanai, da kuma babban hankali.An yi nasarar amfani da shi a fannoni da yawa kamar kiwon lafiya, lafiyar abinci, cututtukan dabbobi da sauransu.
Dogaro da dandamalin fasaha na sama, muna haɓaka kayan gano nucleic acid na hannu waɗanda ba su dogara da hadadden kayan aiki ba, waɗanda ake sa ran za a yi amfani da su ga gano likitan dangi da tushen ciyawa a nan gaba.
![C[5X{X6$0W12D7}Y]_{91Q9](https://www.janmagene.com/uploads/46824609.png)
![AH6)N]%5(8IG2$MDQ)Z`9EV](http://www.janmagene.com/uploads/114c9ea1.png)
Sabbin buƙatun don rigakafi da sarrafa cutar ta SARS-CoV-2 da matsayin kasuwancin kasuwanci
Yayin da annobar duniya ke ci gaba da bunkasa, rigakafin kamuwa da cutar ya shiga wani mataki na daidaitawa.
Domin amsa yadda ya kamata ga halin da ake ciki yanzu da kuma saduwa da bukatun gwajin nucleic acid a cikin yanayi daban-daban, ya zama dole don hanzarta bincike da haɓakawa da ƙungiyar samarwa, ƙaddamar da ƙarin haɗe-haɗe da samfuran gwaji masu sauri waɗanda suka dace da gwajin kan-site, da inganta samfuran gwajin nucleic acid na ƙasata da tsarin fasaha.
A ranar 29 ga watan Yuli, firaministan kasar Li Keqiang ya karbi bakuncin taron zartaswa na majalisar gudanarwar kasar Sin, domin tabbatar da cikakken shirin rigakafin cututtuka da ci gaba, an shirya yadda za a kara karfafa aikin gwajin sinadarin nucleic acid.
Taron ya nuna cewa ya zama dole a hada dukkan bangarorin don hanzarta haɓakawa da ƙaddamar da samfuran tare da ɗan gajeren lokaci, babban hankali da aiki cikin sauƙi.Ƙara horar da ma'aikatan bincike da haɓaka ƙarfin binciken wayar hannu a hankali,Don gwajin gwajin nucleic acid na marasa lafiya a asibitocin zazzabi, kokarin rage rahoton zuwa awanni 4.
A lokacin barkewar cutarSARS-CoV-2Annobar, ƙungiyar Jianma Gene Technology Co., Ltd. ta yi aiki tare da Jami'ar Kimiyya da Fasaha ta Qingdao da Jami'ar Qingdao don bincika mahimman matsalolin, haɓaka samfuran gano ƙwayoyin acid, da samun ganowa cikin kusan mintuna 30.
A ranar 13 ga Maris, 2020, kayan aikin COVID-19 sun sami takardar shedar CE ta EU; A watan Mayu, sun sami cancantar fitar da sabon kambin gwajin reagent na Ma'aikatar Kasuwancin China.
Bututun samfurin ƙwayar cuta mai amfani guda ɗaya wanda kamfaninmu ya haɓaka yana ɗaukar mintuna 3 kawai don kammala sarrafa samfuri da haɓakawa cikin sauri. A halin yanzu, an kammala tattarawa da kuma samar da samfuran kayan aikin likitanci na Class I.Samfurin gano acid nucleic cikin sauri da kamfanin ya haɓaka yana rage lokacin gano acid ɗin zuwa mintuna 30, wanda ke cika cikakkiyar buƙatun rigakafin cutar ta ƙasa da kuma kula da buƙatun jama'a.A halin yanzu, an fitar da samfuran gwajin saurin COVID-19 zuwa Indonesia, Brazil da sauran ƙasashe, kuma abokan ciniki sun gane su.
